Document Detail


Drug reaction, skin care, skin loss.
MedLine Citation:
PMID:  22855079     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Stevens-Johnson syndrome is a rare, potentially fatal drug reaction that causes necrosis of epidermal cells. Early recognition of the syndrome is essential to prevent complications. This article discusses identification, complications, and treatment of Stevens-Johnson syndrome.
Authors:
Karen L Cooper
Related Documents :
2878699 - Subcortical dementia. neuropsychology, neuropsychiatry, and pathophysiology.
3074209 - The concept and nosology of heller's syndrome: review of articles and report of two cases.
22190899 - Phf6 deletions may cause borjeson-forssman-lehmann syndrome in females.
22441639 - Cutaneous manifestations of hyper ige syndrome.
23325749 - Prenatal diagnosis of femoral-facial syndrome: case report.
8132119 - The spasmodic upper-body squeeze: a characteristic behavior in smith-magenis syndrome.
8319709 - Association of hiatus hernia with asplenia syndrome.
24959579 - Long-term parental unemployment in childhood and subsequent chronic fatigue syndrome.
2916909 - Isolated eosinophilic coronary arteritis and eosinophilic myocarditis. a limited form o...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Critical care nurse     Volume:  32     ISSN:  1940-8250     ISO Abbreviation:  Crit Care Nurse     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-08-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8207799     Medline TA:  Crit Care Nurse     Country:  United States    
Other Details:
Languages:  eng     Pagination:  52-9     Citation Subset:  N    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Using evidence-based practice to prevent ventilator-associated pneumonia.
Next Document:  Medical devices and patient safety.